Luc Malo at the Industry, Science and Technology Committee

I'll ask you another question, since I know that Doctors Without Borders is present in many countries that, like Canada, would likely allow medicines to be supplied. I'll talk about second-line medicines, such as second-line antiretrovirals.

Would it be possible, through various agreements, to help open the market to competition, not only here, but throughout the world? Does Doctors Without Borders notice such problems in the rest of the world?